FDA grants Trascenta clearance for Phase III trial of Osemitamab

FDA grants Trascenta clearance for Phase III trial of Osemitamab

Submitted by admin on October 8, 2023 - 2:42pm
Source: 
Clinical Trials Arena
News Tags: 
Osemitamab
gastic cancer
Trascenta
clinical trials
Headline: 
FDA grants Trascenta clearance for Phase III trial of Osemitamab
snippet: 

Osemitamab is advancing towards becoming a global gastric cancer therapy with its progression to Phase III clinical trials in the US.

Do Not Allow Advertisers to Use My Personal information